A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes : What is the evidence so far?

Kurdi, AmanjAbutheraa, NoufAkil, LinaGodman, Brian2021-12-062021-12-062020-12-01Kurdi, A, Abutheraa, N, Akil, L & Godman, B 2020, 'A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes : What is the evidence so far?', Pharmacology Research & Perspectives, vol. 8, no. 6, e00666. https://doi.org/10.1002/prp2.6662052-1707ORCID: /0000-0003-2665-5630/work/97355237https://hdl.handle.net/2164/17624222938216engangiotensin receptor blockersangiotensin-converting enzyme inhibitorscoronavirusCOVID-19 infectionsevere acute respiratory syndrome coronavirus 2R MedicineSupplementary InformationRA systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes : What is the evidence so far?Journal item10.1002/prp2.66686